Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Johnson-and-Johnson stock | $170.69

Own Johnson-and-Johnson stock in just a few minutes.

Johnson & Johnson (JNJ) is a leading drug manufacturers-general business based in the US. It opened the day at $169.88 after a previous close of $168.42. During the day the price has varied from a low of $169.24 to a high of $171.53. The latest price was $170.69 (25 minute delay). Johnson-and-Johnson is listed on the NYSE and employs 134,500 staff. All prices are listed in US Dollars.

How to buy shares in Johnson-and-Johnson

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – JNJ – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Johnson-and-Johnson share price

Use our graph to track the performance of JNJ stocks over time.

Johnson-and-Johnson shares at a glance

Information last updated 2021-05-10.
Open$169.88
High$171.53
Low$169.24
Close$170.69
Previous close$168.42
Change $2.27
Change % 1.3459%
Volume 4,356,866
Information last updated 2021-05-07.
52-week range$131.91 - $172.57
50-day moving average $163.35
200-day moving average $156.72
Wall St. target price$186.80
PE ratio 29.7341
Dividend yield $4.04 (2.41%)
Earnings per share (TTM) $5.66

Buy Johnson-and-Johnson shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Johnson-and-Johnson stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Johnson-and-Johnson price performance over time

Historical closes compared with the close of $170.6868 from 2021-03-10

1 week (2021-04-29) N/A
1 month (2021-04-09) 5.85%
3 months (2021-02-10) 2.32%
6 months (2020-11-10) 15.11%
1 year (2020-05-08) 14.79%
2 years (2019-05-10) 22.75%
3 years (2018-05-10) 36.17%
5 years (2016-05-10) 48.85%

Is Johnson-and-Johnson under- or over-valued?

Valuing Johnson-and-Johnson stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Johnson-and-Johnson's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Johnson-and-Johnson's P/E ratio

Johnson-and-Johnson's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 30x. In other words, Johnson-and-Johnson shares trade at around 30x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Johnson-and-Johnson's PEG ratio

Johnson-and-Johnson's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8651. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Johnson-and-Johnson's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Johnson-and-Johnson's EBITDA

Johnson-and-Johnson's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $28.3 billion.

The EBITDA is a measure of a Johnson-and-Johnson's overall financial performance and is widely used to measure a its profitability.

Johnson-and-Johnson financials

Revenue TTM $84.2 billion
Operating margin TTM 24.85%
Gross profit TTM $54.3 billion
Return on assets TTM 7.98%
Return on equity TTM 23.78%
Profit margin 17.95%
Book value $25.01
Market capitalisation $443.3 billion

TTM: trailing 12 months

Shorting Johnson-and-Johnson shares

There are currently 15.0 million Johnson-and-Johnson shares held short by investors – that's known as Johnson-and-Johnson's "short interest". This figure is 11.8% down from 17.0 million last month.

There are a few different ways that this level of interest in shorting Johnson-and-Johnson shares can be evaluated.

Johnson-and-Johnson's "short interest ratio" (SIR)

Johnson-and-Johnson's "short interest ratio" (SIR) is the quantity of Johnson-and-Johnson shares currently shorted divided by the average quantity of Johnson-and-Johnson shares traded daily (recently around 7.5 million). Johnson-and-Johnson's SIR currently stands at 2. In other words for every 100,000 Johnson-and-Johnson shares traded daily on the market, roughly 2000 shares are currently held short.

However Johnson-and-Johnson's short interest can also be evaluated against the total number of Johnson-and-Johnson shares, or, against the total number of tradable Johnson-and-Johnson shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Johnson-and-Johnson's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Johnson-and-Johnson shares in existence, roughly 10 shares are currently held short) or 0.0057% of the tradable shares (for every 100,000 tradable Johnson-and-Johnson shares, roughly 6 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Johnson-and-Johnson.

Find out more about how you can short Johnson-and-Johnson stock.

Johnson-and-Johnson's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Johnson-and-Johnson.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Johnson-and-Johnson's total ESG risk score

Total ESG risk: 35.8

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Johnson-and-Johnson's overall score of 35.8 (as at 12/31/2018) is pretty weak – landing it in it in the 72nd percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Johnson-and-Johnson is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Johnson-and-Johnson's environmental score

Environmental score: 3.79/100

Johnson-and-Johnson's environmental score of 3.79 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Johnson-and-Johnson is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Johnson-and-Johnson's social score

Social score: 25.14/100

Johnson-and-Johnson's social score of 25.14 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Johnson-and-Johnson is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Johnson-and-Johnson's governance score

Governance score: 14.87/100

Johnson-and-Johnson's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Johnson-and-Johnson is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Johnson-and-Johnson's controversy score

Controversy score: 4/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Johnson-and-Johnson scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that Johnson-and-Johnson has a damaged public profile.

Environmental, social, and governance (ESG) summary

Johnson & Johnson was last rated for ESG on: 2019-01-01.

Total ESG score 35.8
Total ESG percentile 72.38
Environmental score 3.79
Environmental score percentile 7
Social score 25.14
Social score percentile 7
Governance score 14.87
Governance score percentile 7
Level of controversy 4

Johnson-and-Johnson share dividends

49%

Dividend payout ratio: 49.16% of net profits

Recently Johnson-and-Johnson has paid out, on average, around 49.16% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.54% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Johnson-and-Johnson shareholders could enjoy a 2.54% return on their shares, in the form of dividend payments. In Johnson-and-Johnson's case, that would currently equate to about $4.04 per share.

While Johnson-and-Johnson's payout ratio might seem fairly standard, it's worth remembering that Johnson-and-Johnson may be investing much of the rest of its net profits in future growth.

Johnson-and-Johnson's most recent dividend payout was on 7 June 2021. The latest dividend was paid out to all shareholders who bought their shares by 23 May 2021 (the "ex-dividend date").

Have Johnson-and-Johnson's shares ever split?

Johnson-and-Johnson's shares were split on a 2:1 basis on 12 June 2001. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Johnson-and-Johnson shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Johnson-and-Johnson shares which in turn could have impacted Johnson-and-Johnson's share price.

Johnson-and-Johnson share price volatility

Over the last 12 months, Johnson-and-Johnson's shares have ranged in value from as little as $131.9052 up to $172.5739. A popular way to gauge a stock's volatility is its "beta".

JNJ.US volatility(beta: 0.71)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Johnson-and-Johnson's is 0.7086. This would suggest that Johnson-and-Johnson's shares are less volatile than average (for this exchange).

Johnson-and-Johnson overview

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o. b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site